spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DUNNEBACKE, T. H.
Right arrow Articles by DIXON, J. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DUNNEBACKE, T. H.
Right arrow Articles by DIXON, J. S.

Journal of Cell Science, Vol 93, 391-401, Copyright © 1989 by Company of Biologists

Submitted on November 15, 1988
Accepted on March 23, 1989

NACM, a cytopathogen from Naegleria ameba: Purification, production of monoclonal antibody, and immunoreactive material in NACM-treated vertebrate cell cultures

T. H. DUNNEBACKE 1 and J. S. DIXON 1

1 Viral and Rickettsial Disease Laboratory, Division of Laboratories, State of California Department of Health Services, 2151 Berkeley Way, Berkeley, California 94704, USA

An amebic component NACM (Naegleria ameba cytopathogenic material) is obtained from free-living amebae and acts as a cytopathogen in cultured avian and mammalian cells. NACM has been purified and partially characterized using a scheme that includes ammonium sulfate precipitation, liquid chromatographic separations and electrophoretic isolations. The purified NACM product is biologically active. Its properties, revealed by its behavior following treatment with enzymes and during purification, are those of a protein; its size is in the molecular weight range of 36000 and it has an isoelectric point of pH4.2. Monoclonal antibodies have been produced to NACM that prevent its cytopathic activity, and, in dot-blot procedures, identify purified NACM-containing fractions. When used as immunostains, NACM antibodies disclose the presence of immunospecific material both in the amebae and in vertebrate cells inoculated with NACM. In the amebae, the immunostain is located at the tips of the pseudopodia and in the peripheral cytoplasm; in the vertebrate cells, it is absent in uninoculated cells and is not observed in the inoculated cells for the first 3-4 days after the addition of the NACM to the culture. Subsequently, in a time course associated with the development of cytopathic changes observed in the light microscope, immunostaining material develops in the perinuclear cytoplasm where it condenses into a large mass before the cells undergo lysis. On the basis of these results, it appears that NACM represents an unprecedented system in which a protein material from an organism, in the course of destroying unrelated cells, causes the production of a cytoplasmic product that is immunologically recognizable as the inoculating amebic material.

Key words: Naegleria ameba, NACM (Naegleria ameba cytopathogenic material, protein purification, monoclonal antibodies, immunostains, inoculation, cytopathogen, cultured cells

Submitted on November 15, 1988
Accepted on March 23, 1989




This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S. Potter-Perigo, C. Baker, C. Tsoi, K. R. Braun, S. Isenhath, G. M. Altman, L. C. Altman, and T. N. Wight
Regulation of Proteoglycan Synthesis by Leukotriene D4 and Epidermal Growth Factor in Bronchial Smooth Muscle Cells
Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 101 - 108.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M Moudjou, N Bordes, M Paintrand, and M Bornens
gamma-Tubulin in mammalian cells: the centrosomal and the cytosolic forms
J. Cell Sci., January 4, 1996; 109(4): 875 - 887.
[Abstract] [PDF]


© The Company of Biologists Ltd 1989